Sayfa yüklenirken bir hata oluştu.
Teknik ekibimiz bilgilendirildi, ancak sorunun devam etmesi durumunda lütfen e-posta destek widget ile bize ulaşın.
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM EBITDA Multiple | -0,8x - -0,8x | -0,8x |
| Selected Fwd EBITDA Multiple | 5,3x - 5,8x | 5,5x |
| Fair Value | ₩2.235 - ₩2.307 | ₩2.271 |
| Upside | -7,3% - -4,3% | -5,8% |
| Benchmarks | Ticker | Full Ticker |
| INSAN Inc. | A277410 | KOSDAQ:A277410 |
| Genic Co., Ltd. | A123330 | KOSDAQ:A123330 |
| Outin Futures Co., Ltd | A227610 | KOSDAQ:A227610 |
| Icure Pharmaceutical Incorporation | A175250 | KOSDAQ:A175250 |
| Cosmecca Korea Co., Ltd. | A241710 | KOSDAQ:A241710 |
| Medience Co., Ltd. | A014100 | KOSDAQ:A014100 |
| - | - | - |
| Select LTM EBITDA Multiple | |||||||
| Benchmark Companies | |||||||
| A277410 | A123330 | A227610 | A175250 | A241710 | A014100 | ||
| KOSDAQ:A277410 | KOSDAQ:A123330 | KOSDAQ:A227610 | KOSDAQ:A175250 | KOSDAQ:A241710 | KOSDAQ:A014100 | ||
| Historical EBITDA Growth | |||||||
| 5Y CAGR | -12.9% | 21.1% | NM- | NM- | 28.5% | -49.5% | |
| 3Y CAGR | -34.8% | NM- | NM- | NM- | 35.1% | -52.1% | |
| Latest Twelve Months | -63.7% | 445.1% | -202.2% | -5.5% | 45.6% | -378.1% | |
| Historical EBITDA Profit Margin | |||||||
| 5 Year Average Margin | 21.3% | 0.5% | -14.7% | -23.2% | 9.6% | 2.0% | |
| Prior Fiscal Year | 21.0% | -7.9% | 4.8% | -31.8% | 6.8% | 4.6% | |
| Latest Fiscal Year | 8.8% | 15.4% | -4.6% | -32.9% | 14.0% | 0.3% | |
| Latest Twelve Months | 8.8% | 15.4% | -4.6% | -29.5% | 15.3% | -7.6% | |
| Current Trading Multiples | |||||||
| EV / LTM Revenue | 1.95x | 3.53x | 1.21x | 1.18x | 1.22x | 0.17x | |
| EV / LTM EBITDA | 22.2x | 23.0x | -26.2x | -4.0x | 7.9x | -2.2x | |
| EV / LTM EBIT | 77.7x | 29.2x | -12.3x | -2.7x | 10.2x | -1.7x | |
| Low | Mid | High | |||||
| Benchmark EV / LTM EBITDA | -26.2x | 7.9x | 23.0x | ||||
| Historical EV / LTM EBITDA | -22.7x | 11.3x | 17.4x | ||||
| Selected EV / LTM EBITDA | -0.8x | -0.8x | -0.8x | ||||
| (x) LTM EBITDA | (4,282) | (4,282) | (4,282) | ||||
| (=) Implied Enterprise Value | 3,291 | 3,464 | 3,638 | ||||
| (-) Non-shareholder Claims * | 17,565 | 17,565 | 17,565 | ||||
| (=) Equity Value | 20,856 | 21,030 | 21,203 | ||||
| (/) Shares Outstanding | 11.3 | 11.3 | 11.3 | ||||
| Implied Value Range | 1,845.58 | 1,860.91 | 1,876.24 | ||||
| FX Rate: KRW/KRW | 1.0 | 1.0 | 1.0 | Market Price | |||
| Implied Value Range (Trading Cur) | 1,845.58 | 1,860.91 | 1,876.24 | 2,410.00 | |||
| Upside / (Downside) | -23.4% | -22.8% | -22.1% | ||||
| Equity Waterfall | |||||||
| Benchmark Companies | |||||||
| (in millions) | A277410 | A123330 | A227610 | A175250 | A241710 | A014100 | |
| Enterprise Value | 63,158 | 176,402 | 42,243 | 71,640 | 629,699 | 9,670 | |
| (+) Cash & Short Term Investments | 12,537 | 1,290 | 8,129 | 22,492 | 55,394 | 2,883 | |
| (+) Investments & Other | 2,180 | 0 | 1,611 | 8,091 | 2,641 | 33,549 | |
| (-) Debt | (30,882) | (5,940) | (23,526) | (37,728) | (115,928) | (18,867) | |
| (-) Other Liabilities | (329) | 0 | 2,312 | (696) | (78,924) | 0 | |
| (-) Preferred Stock | 0 | 0 | 0 | (2,624) | 0 | 0 | |
| (-) Other | 0 | 0 | 0 | 0 | 0 | 0 | |
| Value of Common Equity | 46,664 | 171,752 | 30,769 | 61,174 | 492,882 | 27,235 | |
| (/) Shares Outstanding | 37.7 | 7.8 | 35.4 | 37.4 | 10.7 | 11.3 | |
| Implied Stock Price | 1,238.00 | 21,950.00 | 868.00 | 1,637.00 | 46,150.00 | 2,410.00 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
| Implied Stock Price (Trading Cur) | 1,238.00 | 21,950.00 | 868.00 | 1,637.00 | 46,150.00 | 2,410.00 | |
| Trading Currency | KRW | KRW | KRW | KRW | KRW | KRW | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |